Medifast (MED) Total Current Liabilities (2010 - 2026)

Medifast's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $42.2 million for Q1 2026.

• Quarterly Total Current Liabilities fell 30.39% year-over-year to $42.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.2 million (down 30.39% YoY) and the FY2025 annual result came in at $43.0 million, down 33.04% from the prior year.
• Total Current Liabilities was $42.2 million for Q1 2026 at Medifast, down from $43.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $188.2 million in Q2 2022 and bottomed at $42.2 million in Q1 2026.
• A 5-year average of $96.5 million and a median of $77.2 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities rose 24.93% — and 2024, when it slumped 41.41%.
• Medifast's Total Current Liabilities stood at $140.9 million in 2022, then plunged by 34.49% to $92.3 million in 2023, then tumbled by 30.49% to $64.2 million in 2024, then plunged by 33.04% to $43.0 million in 2025, then decreased by 1.81% to $42.2 million in 2026.
• Business Quant data shows MED's Total Current Liabilities at $42.2 million in Q1 2026, $43.0 million in Q4 2025, and $46.7 million in Q3 2025.